nida farooqui

nida farooqui

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2022 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
RRRehana Rehman
Rehana Rehman
AAArfa Azhar
Arfa Azhar
ZNZehra Naseem
Zehra Naseem
GHGhulam Haider
Ghulam Haider
NFnida farooqui
nida farooqui
SFSabah Farhat
Sabah Farhat
Aim: This research was aimed to observe apoptotic marker (caspase 3) levels in different groups after treatment with vitamin D in an animal model after inducing polycystic ovary syndrome (PCOS) with dehydroepiandrosterone (DHEA). Materials and Methods: 30 pre-pubertal female sprague dawley dams were recruited. The animals were distributed 10 each in control, PCOS and vitamin D treated groups. In control group, 0.2 ml of sesame oil was given. PCOS group was administered DHEA by the daily dose of 6 mg/kg for 30 days. In vitamin D treated group, animals were injected 6 mg/ kg/day DHEA daily and 120 ng 1, 25(OH) 2D3/100 g subcutaneously once a week. The occurrence of programmed cell death in PCOS by apoptotic marker (caspase 3) levels. Results: The results of this study showed significant weight gain, obesity, changes in caspase 3 levels in PCOS group as compared to control and vitamin D treated group. Conclusion: Administration of vitamin D (120 ng 1, 25(OH) 2D3/100) reduced body weight as well as improved the caspase 3 levels in PCOS induced animals. The results support the effect of vitamin D treatment for metabolic and reproductive characteristic features in PCOS females.

10 September 2025 in Viruses
Verified
Journal Article
Open access
PDF file
Syed Zaryab AhmedSyed Zaryab Ahmed
Syed Zaryab Ahmed
FAFaiq Amin
Faiq Amin
NFnida farooqui
nida farooqui
ZOZhannur Omarova
Zhannur Omarova
SMSyed Faisal Mahmood
Syed Faisal Mahmood
SASyed Hani Abidi
Syed Hani Abidi
Background: In people living with HIV (PLHIV), ongoing neuronal injury has shown a correlation with elevated levels of soluble markers of immune activation, such as sCD163. Additionally, various risk factors, such as injection drug use (IDU), can independently affect immune and cognitive functions, leading to neurocognitive impairment (NCI). However, the potential sCD163-IDU-NCI axis in ART-experienced PLHIV is not clear. This study aims to determine NCI prevalence and investigate the interplay between risk factors and sCD163 in Pakistani PLHIV. Methods: For this cross-sectional study, 150 PLHIV and 30 HIV-negative people who inject drugs (PWID) were recruited using a convenience sampling strategy. NCI screening was performed using the International HIV Dementia Scale (IHDS) tool. Blood samples from PLHIV were used to perform HIV recency testing using the Asante Rapid Recency Assay, and to evaluate sCD163 levels using ELISA. Sociodemographic and clinical data were collected from medical records. Subsequently, descriptive statistics were used to summarize data variables, while comparisons (two and multiple groups) between participants with and without NCI were conducted, respectively, using the Mann–Whitney test or Kruskal–Wallis test for continuous variables, and Fisher’s exact test for categorial variables. Receiver Operating Characteristic (ROC) curve analysis was performed to assess the discriminative ability of sCD163. Logistic regression was used to identify predictors of neurocognitive impairment. Results: The majority of PLHIV had IDU as a high-risk behavior. In PLHIV, the median age was 34.5 years (IQR: 30–41), ART duration was 35 months (IQR: 17–54), and median CD4 count was 326.5 cells/µL (IQR: 116–545.5). Long-term infections (>6 months post-seroconversion; median ART duration: 35 months; median CD4 counts: 326.5 cells/μL) were noted in 83.3% of PLHIV. IHDS-based screening showed that 83.33% (all PLHIV) and 50% (PLHIV with no IDU history) scored ≤ 9 on the IHDS, suggestive of NCI. IHDS-component analysis showed the memory recall to be significantly affected in PLHIV compared to controls (median score 3.2 versus 3.7, respectively, p < 0.001). Regression analysis showed only long-term infection (OR: 2.99, p = 0.03) to be significantly associated with neurocognitive impairment. sCD163 levels were significantly lower in PLHIV with NCI (mean = 7.48 ng/mL, SD = 7.05) compared to those without NCI (mean = 14.82 ng/mL, SD = 8.23; p < 0.0001), with an AUC of 0.803 (95% CI: 0.72–0.88). However, after adjusting for IDU history, the regression analysis showed an odds ratio for sCD163 of 0.998 (95% CI: 0.934, 1.067, p = 0.957), indicating no association between sCD163 levels and NCI. Conclusion: This study reports a high prevalence of NCI in Pakistani PLHIV, and no association between sCD163 and neurocognitive impairment in PLHIV after adjustment for a history of IDU. Long-term infection and IDU were significantly linked to NCI, while only IDU was associated with lower sCD163 levels, regardless of NCI.

4 March 2026 in Viruses
Verified
Journal Article
Open access
PDF file
SMSyed Faisal Mahmood
Syed Faisal Mahmood
DJDr. Hasnain Javed
Dr. Hasnain Javed
ASAyesha Shahbaz
Ayesha Shahbaz
NFnida farooqui
nida farooqui
ARAmna Rafique
Amna Rafique
SASyed Hani Abidi
Syed Hani Abidi
Background: In Pakistan, the number of Human immunodeficiency virus (HIV) cases is increasing significantly, attributed to risk factors such as injection drug use, sexual transmission, etc. However, transmission through hemodialysis units is not well documented. In 2024, an outbreak of HIV cases in Multan, Pakistan, drew alarm from local health authorities due to reports linking it to a large public hospital in South Punjab. Here, we report the molecular epidemiological investigation of the outbreak. Methods: Twenty-five hemodialysis patients identified during the outbreak were enrolled. Blood samples were subjected to DNA extraction and polymerase chain reaction (PCR) amplification. Phylogenetic analysis was conducted using the maximum-likelihood approach in IQ-TREE. For dating phylogenetics, a maximum clade credibility tree (MCC) was constructed using the BEAST tool. The MCC tree was constructed using the Bayesian Skyline model with an uncorrelated lognormal relaxed clock. The VESPA program was used to identify amino acid signatures unique to outbreak sequences compared with Pakistani reference sequences. Results: A total of 25 patients (identified as part of the HIV outbreak) were enrolled. 96% (24 out of 25) also tested positive for Hepatitis C, while none tested positive for Hepatitis B. The age range of patients in the study was 23 to 72 years (median age: 44.88 years). In terms of gender distribution, 13 out of 25 were male. All the sequences were identified as HIV subtype CRF02_AG. Phylogenetic analysis revealed that Multan sequences formed a well-supported monophyletic cluster, indicating shared recent origin. Signature pattern analysis identified a unique molecular fingerprint at 26 nucleotide positions, whereas molecular dating placed the emergence of the cluster between 2023 and 2024, consistent with the outbreak timing. Conclusions: Findings provide biologically plausible evidence of a point-source HIV outbreak linked to lapses in infection prevention and control practices at the hemodialysis unit.

1 August 2022 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
RRRehana Rehman
Rehana Rehman
FAFaiza Alam
Faiza Alam
SASyed Hani Abidi
Syed Hani Abidi
NFnida farooqui
nida farooqui
FJFarrukh Jehan
Farrukh Jehan
Objective: To observe the effect of metformin on the oxidative stress (OS) levels and SIRT1 expression in primary human granulosa cell cultures from infertile females. Methods: This cross-sectional study was conducted from August 2017-July 2019 on ten infertile patients. After written informed consent, the follicular fluid of these subjects was collected for establishing primary human granulosa cell cultures (HGCs), to test the capacity of metformin to reduce OS. The cultured HGCs were divided into (i) control: HGCs without any treatment, (ii) testi: HGCs induced with H2O2 (metformin absent), and (iii) test2: HGCs treated with metformin after H2O2 induction. Baseline OS (control group) was estimated, it was induced and measured by an increase in optical density (OD) (testi &test 2). Finally, test2 was incubated with metformin (1 ml of 100 mmol/1 concentration) and it effect on the levels of OS were determined by Mishra OS assay. Effect of metformin modulating SIRT1 expression in OS-induced cells was analyzed using quantitative-PCR. Results: Age of female subjects was 32.04 +/- 2.29years and BM I was 27.61 +/- 2.15 kg/m(2). Test (OS induced) samples gave an OD of 0.28 (0.16-0.40) while control HGC samples gave an OD; 0.153 (0.09-0.23). Test cells showed significant reduction in ODs after metformin treatment. The relative expression of SIRT1 in metformin untreated and treated cells was found to be 61.5% and 80%, respectively. Conclusion: Metformin was found to suppress OS in HGCs and increases the expression of SIRT1 in OS induced environment of primary cell cultures, suggesting a relationship between metformin, SIRT1 expression, and reduction of OS.